Roots Analysis has conducted an in-depth research on digital therapeutics, analyzing the market landscape and affiliated products, to develop a detailed and informed perspective regarding the associated opportunity
Key Market Insights
- The independent opinions of representatives from prominent companies corroborate the fact that the opportunities associated with digital therapeutics are rapidly rising and have enormous potential in the healthcare sector
- Advances in the field of information technology have enabled the development of several digital therapeutic software solutions, which are capable of catering to the existing unmet needs in the healthcare domain
- Considering the shear volume of players involved in developing these novel solutions and the ongoing pace of innovation in this field, digital therapeutics market is in an accelerated phase of growth
- The relative strength (and eventual success) of a company is dependent on several factors, such as years of experience, size of its employee base, stage of fundraising and location of headquarters
- Owing to the numerous benefits offered by digital therapeutics, the adoption of such solutions has increased in the recent past
- With the growing interest in application of digital therapeutics, it is imperative that both new and existing brands identify ways to distinguish themselves from other industry stakeholders, in order to gain a competitive edge
- Over the last decade, owing to the opportunities associated with digital therapeutics, several industry and non-industry players have collectively invested USD 8.9 billion, across 445 funding instances
- A significant proportion of the amount has been raised via venture capital investors, however, there are a few promising ventures that have already been publicly listed in various stock exchanges
- Driven by the ongoing pace of innovation in this field and sufficient financial support from shareholders, the digital health market is likely to present lucrative opportunities for interested investors
- Insights from an in-depth analysis of publicly disclosed financial statements, including product sales and earnings, offer the means to evaluate a company’s competitive position in the market
- Financial ratios provide a deeper perspective onto a firm’s current and likely future capability to grow and thrive amidst the evolving competition in the industry
- It offers insights to help investors identify and evaluate potential investment opportunities through a detailed analysis of recent trading activity, including price movement and volume
- A variety of indicators have been used in order to scrutinize the supply and demand dynamics related to a security, which is believed to influence changes in price, volume and volatility of a stock
- Akili Interactive is a US based digital therapeutics company working towards bringing together science and entertainment with great user experience, thereby revolutionizing medicine design and delivery
- Digital therapeutic solution (public) ventures adopt varying strategies and continually monitor both internal and external risk parameters, in order to detect anomalies as early as possible
- Given the cost saving potential of digital health solutions and growing interest of big pharma players, the digital therapeutics market is likely to grow at an accelerated pace
- Investors that have entered the digital therapeutics market during the onset of the internet revolution, have reported multifold capital gains, resulting in a strong spur in investment activity in this domain
- Based on strength and qualitative understanding of value offered, several companies have been shortlisted as potential acquisition targets for investors
Table of Contents
Excel Deliverables
EXCEL DELIVERABLE
1. INNOVATORS AND PRODUCTS DATASET
1.1. Analysis Notes
1.2. Innovator Landscape
1.3. Product Landscape
1.4. Value Proposition
1.5. Key Acquisition Targets
1.6. AI – AVII Appendices
2. FUNDING AND INVESTMENT ANALYSIS
2.1. Analysis Notes
2.2. Summary Dashboard
2.3. Capital Investments in Digital Therapeutics
2.4 AI – AIV Appendices
3. FUNDAMENTAL AND TECHNICAL FINANCIAL ANALYSIS
The information presented in this analysis is spread across separate MS Excel sheets, which provide information on key financial parameters and competitive insights based on historical and prevalent trends.
4. BUSINESS RISK ANALYSIS
4.1. Analysis Notes
4.2. Business Risk Data
4.3. AI – AVII Appendices
5. MARKET FORECAST AND OPPORTUNITY ANALYSIS
5.1. Analysis Notes
5.2. Market Forecast and Opportunity Analysis: Summary
5.3. Market Forecast and Opportunity Analysis: Base Scenario
5.4. Market Forecast and Opportunity Analysis: Conservative Scenario
5.5. Market Forecast and Opportunity Analysis: Optimistic Scenario
6. RETURN ON INVESTMENT
6.1. Analysis Notes
6.2. Estimated RoI for Investors in Company A
6.3. Estimated RoI for Investors in Company B
6.4. Estimated RoI for Investors in Company C
POWERPOINT DELIVERABLE
1 CONTEXT
2 PROJECT APPROACH
3 PROJECT OBJECTIVES
4 EXECUTIVE SUMMARY
Section I: Need for Digital Therapeutics and Innovators Landscape
5 THE DIGITAL THERAPEUTICS MARKET
5.1. Overview
5.2. Historical Milestones
5.3. Key Types of Solutions
5.4. Key Strategic Initiatives
5.5. Key Concepts, Marketed Products and Challenges
6. DIGITAL THERAPEUTICS: INNOVATOR LANDSCAPE
6.1. Methodology
6.2. Innovators in the Digital Therapeutics Market
6.3. Analysis of Competitive Landscape
6.4. Conclusion
7. DIGITAL THERAPEUTICS: PRODUCT LANDSCAPE AND COMPANY HEALTH INDEXING
7.1. List of Digital Therapeutics
7.2. Analysis of Product Landscape
7.3. Health Indexing Methodology
7.4. Company Health Indexing
8. VALUE PROPOSITION ANALYSIS
8.1. Overview and Methodology
8.2. Outreach-related Value
8.3. Developer Value
8.4. Product-related Value
8.5. Value to Patients
8.6. Concluding Remarks
9. COMPANY COMPETITIVENESS ANALYSIS
9.1. Overview and Methodology
9.2. Company Competitiveness Analysis
Section II Analysis of Investments
10 FUNDING AND INVESTMENT ANALYSIS
10.1. Overview
10.2. Analysis by Type of Funding
10.3. Analysis by Geography and Most Active Players
10.4. Analysis of Trends Across Various Funding Categories
10.5. Summary of Funding and Investments
Section III Financial Analysis and Assessment of Business Risks
11 FINANCIAL ANALYSIS OF PUBLIC VENTURES
11.1. Fundamental Financial Analysis Overview
11.2. Financial Ratios (Interpretation Guide)
11.3. Case Study 1
11.4. Technical Financial Analysis Overview
11.5. Technical Indicators (Interpretation Guide)
11.6. Case Study 2
12. COMPANY PROFILES OF PUBLIC VENTURES
12.1 Akili Interactive
12.2. Better Therapeutics
12.3. Brain+
12.4. Dario Health
12.5. Ehave
12.6. Mindcure
12.7. Newtopia
12.8. Pear Therapeutics
13. BUSINESS RISK ANALYSIS
13.1. Overview and Methodology
13.2. Operations-related Risks
13.3. Business-related Risks
13.4. Financial / Asset-related Risks
13.5. Product / Technology Risks
13.6. Other Risks
13.7. Business Risk Summary
Section IV Market Forecast and Opportunity Analysis
14. MARKET FORECAST
14.1. Overview and Methodology
14.2. Global Digital Therapeutics Market, 2023-2035
14.3. Distribution Across Key Market Segments
Section V Analysis of Returns on Investment and Key Acquisition Targets
15. ANALYSIS OF RETURNS ON INVESTMENT
15.1. Overview and Methodology
15.2. Case Studies
16. KEY ACQUISITION TARGETS
16.1. Overview
16.2. List of Key Acquisition Targets
17. CONCLUSION
18. APPENDICES
To view more details on this report, click on the link
You may also be interested in the following titles:
| Digital Biomanufacturing Market |
| Buffer Preparation Market Women’s digital health market Global digital therapeutics market |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
